Zeria Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, and reagents in Japan and internationally. It also provides cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, health equipment, hygiene facilities and equipment, beauty appliances, and measuring and analytical equipment. The company offers products in the gastrointestinal field, including therapeutic agents for functional dyspepsia, ulcerative colitis, Crohn's disease, and gastritis and ulcers; zinc containing anti-ulcerants; oral bowel cleansing agents; laxatives; therapeutic agents for hypophosphatemia; long-acting calcium channel blockers; oral NSAID; anti-leukopenia after radiotherapy products; sclerosing agent for varicose veins; anti-inflammatory topical blood circulation enhancers; non-steroidal anti-inflammatory ophthalmic solutions; absorbable topical hemostat products; and proton pump inhibitors. In addition, it offers consumer healthcare products, such as nutritional health drugs, cold remedies, ophthalmic solutions, anti-inflammatory/analgesics, hemorroidal remedies, dermal remedies, quasi-drugs/cosmetics, nutrient tonics, and food for specified health uses. The company was formerly known as Zeria Yakusho Kenkyusho Co., Ltd. and changed its name to Zeria Pharmaceutical Co., Ltd. in May 1970. Zeria Pharmaceutical Co., Ltd. was founded in 1955 and is headquartered in Tokyo, Japan.
Zeria Pharmaceutical Dividend Announcement
• Zeria Pharmaceutical announced a semi annually dividend of ¥0.00 per ordinary share which will be made payable on . Ex dividend date: 2025-03-28
• Zeria Pharmaceutical's trailing twelve-month (TTM) dividend yield is 1.95%
Zeria Pharmaceutical Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2025-03-28 | ¥0.00 | semi annually | |
2024-09-27 | ¥23.00 | semi annually | 2024-12-01 |
2024-03-28 | ¥22.00 | semi annually | |
2023-09-28 | ¥22.00 | semi annually | 2023-12-01 |
2023-03-30 | ¥22.00 | semi annually | 2023-06-30 |
2022-09-29 | ¥18.00 | semi annually | 2022-12-01 |
2022-03-30 | ¥17.00 | semi annually | 2022-06-30 |
2021-09-29 | ¥17.00 | semi annually | 2021-12-01 |
2021-03-30 | ¥17.00 | semi annually | 2021-06-30 |
2020-09-29 | ¥17.00 | semi annually | 2020-12-01 |
2020-03-30 | ¥17.00 | semi annually | 2020-06-29 |
2019-09-27 | ¥17.00 | semi annually | 2019-12-02 |
2019-03-27 | ¥17.00 | semi annually | 2019-06-28 |
2018-09-26 | ¥17.00 | semi annually | 2018-12-03 |
2018-03-28 | ¥17.00 | semi annually | 2018-06-29 |
2017-09-27 | ¥17.00 | semi annually | 2017-12-01 |
2017-03-29 | ¥16.00 | semi annually | 2017-06-30 |
2016-09-28 | ¥16.00 | semi annually | |
2016-03-29 | ¥16.00 | semi annually | |
2015-09-28 | ¥15.00 | semi annually | |
2015-03-27 | ¥15.00 | semi annually | |
2014-09-26 | ¥15.00 | semi annually | |
2014-03-27 | ¥15.00 | semi annually |
Zeria Pharmaceutical Dividend per year
Zeria Pharmaceutical Dividend growth
Zeria Pharmaceutical Dividend Yield
Zeria Pharmaceutical current trailing twelve-month (TTM) dividend yield is 1.95%. Interested in purchasing Zeria Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:
Zeria Pharmaceutical Financial Ratios
Zeria Pharmaceutical Dividend FAQ
Other factors to consider when evaluating Zeria Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Zeria Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Zeria Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Zeria Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Zeria Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Zeria Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Zeria Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Zeria Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Zeria Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Zeria Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Zeria Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.